In2Pharma
  • Home
  • Services
    • Regulatory Affairs
    • Quality Assurance
    • Publicity and Compliance
    • Medical writing & training
    • Vigilance
  • About Us
  • News
  • Contact
Select Page
MDR implementation: MD manufacturers to comply with conditions for transition period

MDR implementation: MD manufacturers to comply with conditions for transition period

by In2Pharma | Jul 2, 2024 | News

The Netherlands In 2021, the EU-regulations for medical devices regarding safety and efficacy have become more strict under the implementation of the MDR. This implies that some CE labels have to be updated and a selection of medical devices now need a CE-label, while...

Recent Posts

  • Verify Luxembourg MA Numbers in XEVMPD
  • Rates advice KOAGKAG
  • Announcement of changes in EU pharmacovigilance legislation
  • New European regulation for Health Technology Assessment
  • Pharma.be supports interactions with patients

Follow Us

  • Facebook
  • LinkedIn
Privacy Policy | Cookie Policy | BTW BE 895730662 | +32 16 89 16 00| info@in2pharma.com | Terloonststraat 22, 1910 Kampenhout, België